HomeMTNB • NYSEAMERICAN
add
Matinas BioPharma Holdings Inc
Previous close
$0.60
Day range
$0.59 - $0.67
Year range
$0.47 - $9.72
Market cap
3.38M USD
Avg Volume
28.12K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.66M | -25.20% |
Net income | -8.43M | -58.69% |
Net profit margin | — | — |
Earnings per share | -0.81 | 46.29% |
EBITDA | -3.95M | 31.82% |
Effective tax rate | 0.94% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.28M | -47.05% |
Total assets | 12.64M | -49.65% |
Total liabilities | 5.05M | -13.78% |
Total equity | 7.59M | — |
Shares outstanding | 5.09M | — |
Price to book | 0.40 | — |
Return on assets | -60.78% | — |
Return on capital | -68.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -8.43M | -58.69% |
Cash from operations | -3.51M | 23.35% |
Cash from investing | 500.00K | -83.11% |
Cash from financing | -1.00K | 0.00% |
Net change in cash | -3.01M | -85.86% |
Free cash flow | -1.33M | 50.82% |
About
Founded
2013
Headquarters
Website
Employees
3
